â?¢ Patients with renal or hepatic dysfunction (Serum creatinine > 1.5 mg/dL and serum transaminase levels >120 U/L) <br/ >â?¢ Patients with clinical heart failure/known CAD <br/ >â?¢ Known cases of neoplasms or immunodeficiency syndromes <br/ >â?¢ Patients who are on chemotherapy, immunosuppressive agents, steroids or antiviral agents, or have received in the preceding 4 weeks <br/ >â?¢ Pregnant and lactating patients <br/ >â?¢ Uncooperative patients (in the opinion of the investigator, if it is difficult to ensure patient cooperation during the study) <br/ >

â?¢ Patients with renal or hepatic dysfunction (Serum creatinine > 1.5 mg/dL and serum transaminase levels >120 U/L) <br/ >â?¢ Patients with clinical heart failure/known CAD <br/ >â?¢ Known cases of neoplasms or immunodeficiency syndromes <br/ >â?¢ Patients who are on chemotherapy, immunosuppressive agents, steroids or antiviral agents, or have received in the preceding 4 weeks <br/ >â?¢ Pregnant and lactating patients <br/ >â?¢ Uncooperative patients (in the opinion of the investigator, if it is difficult to ensure patient cooperation during the study) <br/ >

N/A

N/A

â?¢ Patients with renal or hepatic dysfunction (Serum creatinine > 1.5 mg/dL and serum transaminase levels >120 U/L) <br/ >â?¢ Patients with clinical heart failure/known CAD <br/ >â?¢ Known cases of neoplasms or immunodeficiency syndromes <br/ >â?¢ Patients who are on chemotherapy, immunosuppressive agents, steroids or antiviral agents, or have received in the preceding 4 weeks <br/ >â?¢ Pregnant and lactating patients <br/ >â?¢ Uncooperative patients (in the opinion of the investigator, if it is difficult to ensure patient cooperation during the study) <br/ >

â?¢ Patients with renal or hepatic dysfunction (Serum creatinine > 1.5 mg/dL and serum transaminase levels >120 U/L) <br/ >â?¢ Patients with clinical heart failure/known CAD <br/ >â?¢ Known cases of neoplasms or immunodeficiency syndromes <br/ >â?¢ Patients who are on chemotherapy, immunosuppressive agents, steroids or antiviral agents, or have received in the preceding 4 weeks <br/ >â?¢ Pregnant and lactating patients <br/ >â?¢ Uncooperative patients (in the opinion of the investigator, if it is difficult to ensure patient cooperation during the study) <br/ >